Satellos Bioscience (MSLE) Enterprise Value (2023 - 2026)
Satellos Bioscience (MSLE) posted quarterly Enterprise Value of -$69.9 million for Q1 2026, down 152.3% quarter-over-quarter from -$27.7 million in Q4 2025.
Satellos Bioscience (MSLE) Enterprise Value (2023 - 2026) Analysis & Trends
Satellos Bioscience (MSLE) has reported Enterprise Value for 4 consecutive years, with -$69.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value changed N/A year-over-year to -$69.9 million; the TTM figure through Mar 2026 stood at -$69.9 million (changed N/A YoY), while the FY2025 annual figure was -$27.7 million, up 44.59% from the prior year.
- Enterprise Value slipped to -$69.9 million in Q1 2026 per MSLE's latest filing, from -$27.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$27.7 million in Q4 2025 and bottomed at -$69.9 million in Q1 2026.
- Historically, Enterprise Value has averaged -$44.2 million across 4 years, with a median of -$39.5 million in 2023.
- Annual changes were most pronounced in 2024 — Enterprise Value tumbled 71.97% — and 2025, when it surged 44.59%.
- Satellos Bioscience's Enterprise Value stood at -$29.1 million in 2023, then sank by 71.97% to -$50.0 million in 2024, then soared by 44.59% to -$27.7 million in 2025, then slumped by 152.3% to -$69.9 million in 2026.
- Business Quant data shows MSLE's Enterprise Value at -$69.9 million in Q1 2026, -$27.7 million in Q4 2025, and -$50.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Satellos Bioscience | 208.31 Mn | 208.31 Mn | - | -61.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.91 Mn |
| Dec 31, 2025 | -27.71 Mn |
| Dec 31, 2024 | -50.00 Mn |
| Dec 31, 2023 | -29.08 Mn |